Company: FLDDW
Filing Date: 2025-04-11
Form Type: 424B3
Source: 0001213900-25-031004
Chunk: 107

Company: Fold Holdings, Inc.
Filing Date: 2025-04-11
Form: 424B3
Chunk 107
---
ness. In addition, we may incur additional indebtedness, the terms
of which may further restrict or prevent us from paying dividends on our Common Stock. As a result, you may have to sell some or all of
your Common Stock after price appreciation in order to generate cash flow from your investment, which you may not be able to do. Our inability
or decision not to pay dividends, particularly when others in our industry have elected to do so, could also adversely affect the market
price of our Common Stock.

If securities or industry
analysts do not publish research or reports about our business or publish negative reports, the market price of our Common Stock and Warrants
could decline.

The trading market for our Common
Stock and Warrants will be influenced by the research and reports that industry or securities analysts publish about us or our business.
We may be unable or slow to attract research coverage and if one or more analysts cease coverage of us, the price and trading volume of
our securities would likely be negatively impacted. If any of the analysts that may cover us change their recommendation regarding our
securities adversely, or provide more favorable relative recommendations about our competitors, the price of our securities would likely
decline. If any analyst that may cover us ceases covering us or fails to regularly publish reports on us, we could lose visibility in
the financial markets, which could cause the price or trading volume of our securities to decline. Moreover, if one or more of the analysts
who cover us downgrades our Common Stock or Warrants if our reporting results do not meet their expectations, the market price of our
Common Stock and Warrants could decline.

<div align='center'>54

USE
OF PROCEEDS</div>

We will not receive any proceeds
from the sale of shares of Common Stock or Warrants by the Selling Securityholders pursuant to this prospectus. We will receive proceeds
from the exercise of the Warrants for cash, but not from the sale of the shares of Common Stock issuable upon such exercise.

The Company may receive up to an aggregate of approximately $35 million
from the exercise of the Warrants, assuming the exercise in full of all of the Warrants for cash. There is no assurance that the holders
of the Warrants will elect to exercise any or all of the Warrants. To the extent that Warrants are exercised on a “cashless basis,”
the amount of cash we would receive from the exercise of the Warrants will decrease, potentially to zero. On April